Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.004 Å; disorder in main residue; R factor = 0.063; wR factor = 0.178; data-to-parameter ratio = 14.8.
In the title molecular salt (systematic name: 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-1, 6,7,8,9,9a-hexahydropyrido À , the piperidine ring displays a chair conformation and its N atom is protonated; the N-H bond is in an axial orientation. The ring bearing the hydroxy group exhibits a half-chair conformation. The hydroxy group as well as the adjacent methylene group are disordered over two sets of sites in a 0.823 (5):0.177 (5) ratio. In the crystal, O-HÁ Á ÁN, O-HÁ Á ÁO, N-HÁ Á ÁO and N-HÁ Á ÁN hydrogen bonds connect the components into a three-dimensional network.
Related literature
For polymorphism of pharmaceutical materials, see: Luo et al. (2012) . For background to the anti-psychotic drug paliperidone, see: Spina & Crupi (2011) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Figure 1
The molecular structure of the title compound with displacement ellipsoids drawn at the 30% probability level. ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

